You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Researchers who set out to compare the ability of SNP and comparative genomic hybridization microarray platforms to detect copy number variation in autusm spectrum disorder managed to identify 16 genes that hadn't been associated with ASD before.
Population Diagnostics, Akonni Biosystems, Luminex, Qiagen, Illumina, and others awarded US patents.
The company will work with Stony Brook University Medical Center to identify and characterize genetic variants for Parkinson's disease.
Patents awarded to the UK Defense Secretary, U of South Florida, Quest Diagnostics, Affymetrix, Epigenomics, Boston University, Chinese government, and Population Diagnostics
Agilent Technologies, Stanford University, Boston University, UAB Research Foundation, Illumina, Population Diagnostics
Klaus Lindpainter is the new VP of R&D and CSO at Strategic Diagnostics; Intrexon appoints Thomas Goralski as senior VP; WARF loses director of licensing Craig Christianson, and more.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.